CMPX — COMPASS THERAPEUTICS INC

Ownership history in ORBIMED ADVISORS LLC  ·  17 quarters on record

This page tracks every 13F SEC filing in which ORBIMED ADVISORS LLC reported a position in COMPASS THERAPEUTICS INC (CMPX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.15% (2022 Q4)
Avg. % of fund
1.03%
First filed
2021 Q4
Last filed
2025 Q4
Quarters held
17
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 15,219,994 — 0% 1.67% $81.7M $5.37
2025 Q3 UNCHANGED 15,219,994 — 0% 1.25% $53.3M $3.50
2025 Q2 REDUCED 15,219,994 -7,142,856 -31.9% 0.99% $39.6M $2.60
2025 Q1 UNCHANGED 22,362,850 — 0% 1.01% $42.5M $1.90
13 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    CMPX price (monthly, adj. close)

Other funds also holding CMPX

As of 2025 Q4 — sorted by position size

Birchview Capital, LP 3Y 7Y 5.01% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 4.45% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 3.99% CAXTON CORP 3Y 7Y 3.7% Vivo Capital, LLC 3Y 7Y 3.31% Monashee Investment Management LLC 3Y 7Y 3.03% Seven Fleet Capital Management LP 2.32% Palo Alto Investors LP 3Y 7Y 1.89% SUVRETTA CAPITAL MANAGEMENT, LLC 3Y 7Y 1.56% BVF INC/IL 3Y 7Y 1.4%
← Back to ORBIMED ADVISORS LLC Holdings